P. Virgo

发表

Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.

P. Vyas, A. Mead, T. Enver, 2011, Cancer cell.

Identification of the CD33‐related Siglec receptor, Siglec‐5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias

P. Virgo, C. Erickson-Miller, J. Hows, 2003, British journal of haematology.

Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations.

R. Hills, N. Russell, J. Cavenagh, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Prospective Study to Evaluate a Diagnostic Algorithm for the Use of Fluid Lymphocyte Subset Analysis in Undiagnosed Unilateral Pleural Effusions

M. Brett, N. Maskell, A. Medford, 2017, Respiration.

A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma

N. Maskell, P. Virgo, A. Morley, 2018, BMC Cancer.

Expression of CD33 is a predictive factor for effect of Gemtuzumab Ozogamicin at different doses in adult acute myeloid leukemia

R. Hills, N. Russell, N. Khan, 2016, Leukemia.

Expression of CD 33 is a predictive factor for effect of Gemtuzumab Ozogamicin at different doses in adult acute myeloid leukemia

Amanda, R. Hills, N. Russell, 2016 .

Laboratory clues to immunodeficiency; missed chances for early diagnosis?

D. J. Unsworth, S. Johnston, P. Virgo, 2014, Journal of Clinical Pathology.

Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia.

P. Kearns, P. Virgo, C. Cox, 2007, Blood.

Running Title: T-ALL progenitor cells

P. Kearns, P. Virgo, A. Blair, 2006 .

Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro

N. Scolding, P. Virgo, A. Wilkins, 2017, Multiple sclerosis.

Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now

D. Grimwade, P. Virgo, N. Goulden, 2006, British journal of haematology.

Prognostic relevance of treatment response measured by flow cytometric residual disease detection in older patients with acute myeloid leukemia.

Robert K Hills, R. Hills, N. Russell, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency.

M. Gompels, P. Virgo, R. J. Lock, 2002, Journal of clinical pathology.

Flow cytometry in clinical pathology

P. Virgo, Paul F Virgo, Graham J Gibbs, 2012, Annals of clinical biochemistry.

Genetically distinct leukemic stem cells in human CD34− acute myeloid leukemia are arrested at a hemopoietic precursor-like stage

P. Vyas, A. Mead, C. Craddock, 2016, The Journal of experimental medicine.

Pitfalls in the performance and interpretation of clinical immunology tests

D. J. Unsworth, P. Virgo, R. J. Lock, 2008, Journal of Clinical Pathology.

Immunoglobulin E deficiency: a forgotten clue pointing to possible immunodeficiency?

D. J. Unsworth, P. Virgo, R. J. Lock, 2011, Annals of clinical biochemistry.

Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting;

Jeremy Hancock, Margaret Helliwell, Sarah Lawson, 2009, Haematologica.

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia

I. Weissman, P. Vyas, C. Craddock, 2013, Leukemia.

Early emergence of PNH-like T cells after allogeneic stem cell transplants utilising CAMPATH-1H for T cell depletion

J. Cornish, P. Virgo, N. Goulden, 2005, Bone Marrow Transplantation.

High peripheral blood progenitor cell counts enable autologous backup before stem cell transplantation for malignant infantile osteopetrosis.

A. Flanagan, J. Moppett, P. Orchard, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Co-Existence of LMPP-Like and GMP-Like Leukemia Stem Cells In Acute Myeloid Leukemia

P. Woll, P. Vyas, A. Mead, 2010 .

Rapid diagnosis and characterization of acute promyelocytic leukaemia in routine laboratory practice.

P. Virgo, R. J. Lock, R. Evely, 2004, Clinical and laboratory haematology.

CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial

G. Lucchini, P. Veys, F. Farzaneh, 2021, Nature Medicine.

Paediatric ambiguous lineage leukaemia with monocytic differentiation at diagnosis: case series and review of literature

J. Irving, P. Virgo, J. Payne, 2021, British journal of haematology.

Sampling endoscopically normal large bowel mucosa from patients presenting with elevated faecal calprotectin levels is not clinically justified

N. Wong, P. Virgo, M. Wallage, 2021, Journal of Clinical Pathology.

An immunophenotypic pre‐treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34+ CD38low blasts

P. Vyas, R. Hills, N. Russell, 2015, British journal of haematology.

T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy

P. Amrolia, P. Virgo, R. Dillon, 2023, Blood advances.

A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions

N. Maskell, B. Kahan, J. Harvey, 2012, European Respiratory Journal.

T-replete cord transplants give superior outcomes in high risk and relapsed/refractory paediatric myeloid malignancy

P. Amrolia, P. Virgo, R. Dillon, 2023 .

Evaluating participants' perceptions of a functional physical fitness assessment for those aged 60 years and over conducted in the community by student physiotherapists

K. Bannigan, L. Bunn, E. Candy, 2021, International Journal of Therapy and Rehabilitation.

Type 1 diabetes mellitus masking primary antibody deficiency

D. J. Unsworth, S. Johnston, P. Virgo, 2000, Journal of clinical pathology.

Molecular MRD Monitoring Is Feasible in the Majority of Children with AML and Is Highly Predictive of Outcome: Results from the International MyeChild01 Study

P. Vyas, N. Potter, A. Baruchel, 2019, Blood.